Skip to main content
OpenTrials
Completed

NCT Number: NCT05765123

Gastric Emptying Validation Pilot Study (MRI Val)

The primary aim of this study is to assess (in healthy volunteers) the rate at which a glucose drink leaves the stomach by sequential magnetic resonance imaging (MRI) of the stomach contents using a 0.5 tesla upright MRI scanner, and comparing with the rate derived from a standard method which uses a stable isotope tracer and breath testing. The main question it aims to answer are:

* Do MRI derived images of stomach contents at low magnetic field (0.5 Tesla) have sufficient resolution to provide a reproducible assessment of gastric emptying * What is the agreement and relationship between the rate of gastric emptying determined from the 2 methods Participants will be asked to attend the imaging centre on one occasion in the morning after fasting from midnight and to sit within an upright MRI scanner for a period of approximately 140 minutes. Images of their stomach will be taken before and for 2 hours after consuming a drink containing glucose and a small amount of sodium acetate which contains a heavier form of carbon. Before each image is taken, participants will be asked to exhale into a 500ml bag to collect a breath sample.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sir Peter Mansfield Imaging Centre

Nottingham, Notts, NG72UH, United Kingdom

About this study

The rate at which food empties from the stomach is a key assessment made in appetite and metabolic research, as well as studies investigating gastrointestinal function in health and disease. This assessment can be achieved by measuring the volume of the stomach contents at timepoints after eating using magnetic resonance imaging (MRI) and calculating the gastric emptying rate from the decrease in volume which occurs over time. However, these measures are traditionally made when the individual is lying supine within the bore of the MRI machine and this postural position may impact the rate that food empties from the stomach. A low-field 0.5 Tesla 'upright' MRI scanner could address the problem of measuring gastric emptying rate when supine. However, the resolution of the images obtained are poorer than those obtained at higher field strengths (e.g. at 3 Tesla). The primary aim of this study is to compare gastric emptying kinetics assessed by sequential MR imaging of the stomach with a standard method which uses a stable isotope tracer (13-Carbon labelled sodium acetate) and breath testing. Twelve healthy, non-obese volunteers (18 to 60 years old) will attend the imaging centre on one occasion in the morning after fasting from midnight and sit within an upright MRI scanner for a period of approximately 140 minutes. Images of their stomach will be taken before and every 5 minutes for 1 hour, and every 10 minutes for the following hour, after consuming a drink containing glucose and 150mg of sodium acetate which contains a heavier (non-radioactive) form of carbon (carbon-13). Before each image is taken, participants will exhale into a 500ml bag to enable a breath sample to be collected. Breath samples will subsequently be analysed for carbon-13 enrichment of expired carbon dioxide (CO2) using mass spectrometry.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy (health status will be confirmed at screening).
  • Able to fully comprehend the informed consent process and give informed consent.
  • BMI <30 kg/m2

Exclusion criteria

  • Known contraindication to MRI scanning (for example, pacemaker/implanted defibrillator, aneurysm clips, implanted programmable device, intra-ocular metallic fragment, claustrophobia)
  • Major psychiatric, cognitive or mood disorder.
  • Any other significant chronic medical conditions, including diabetes (type 1 and 2), asthma and epilepsy.
  • Any acute major illness or surgery within one year prior to participation.
  • Glucose intolerance (as assessed by a finger-prick test at screening).
  • Having taken part in a research study in the last 3 months involving invasive procedures, ionising radiation or an inconvenience allowance.

Treatment and study plan

Oral glucose tolerance test

Diagnostic Test

A drink containing 75g of glucose together with 150mg carbon-13 sodium acetate in 300ml water

Primary outcomes

  1. MRI gastric emptying rate (T50)

    Time frame: assessment made over 120 minutes (timepoints from 0 minutes to 120 minutes after consuming test drink)

    Gastric emptying rate (ml/min) derived from the decrease in volume of gastric contents

  2. 13-Carbon labelled Sodium Acetate Breath test gastric emptying rate (T50)

    Time frame: assessment made over 120 minutes (timepoints from 0 minutes to 120 minutes after consuming test drink)

    Gastric emptying rate derived (ml/min) from the rate of appearance of carbon 13 labelled CO2 in the breath

Secondary outcomes

  1. Volume of gastric contents

    Time frame: assessed at timepoints from 0 minutes to 120 minutes after consuming the test drink (timepoints 0,5,10,15,20,25,30,35,40,45,50,55,60,70,80,90,100,110,and 120 minutes)

    Volume of gastric contents determined from MRI images (ml)

  2. Carbon 13-enrichment of breath CO2

    Time frame: assessed at timepoints from 0 minutes to 120 minutes after consuming the test drink (timepoints 0,5,10,15,20,25,30,35,40,45,50,55,60,70,80,90,100,110,and 120 minutes)

    carbon 13 labelled CO2 content in the breath measured using mass spectrometry

Sponsors and collaborators

Lead sponsor

University of Nottingham

Other

Registry information

Official study title

A Pilot, Validation Study to Assess Sequential MRI Scanning on a 0.5 Tesla Upright Scanner as a Method to Determine Gastric Emptying Rate

Acronym: MRIVal

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 13, 2023
Registry last updated
Jul 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.